Solid Biosciences Inc.

SLDB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017
Assets
Cash & Equivalents $52.1M
Accounts Receivable
Inventory
Total Current Assets $70.7M
Property, Plant & Equipment $2.4M
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $76.2M
Liabilities
Accounts Payable $5.1M
Total Current Liabilities $11.3M
Long-Term Debt
Total Liabilities $11.3M
Stockholders' Equity
Retained Earnings $-124.3M
Total Stockholders' Equity $-59.3M
← Newer Page 2 of 2 Older →